My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Anales de Medicina Interna
Print version ISSN 0212-7199
Abstract
DOMINGUEZ RODRIGUEZ, A. et al. Plasma homocysteine levels in Spanish patients with coronary artery disease. An. Med. Interna (Madrid) [online]. 2002, vol.19, n.4, pp.12-18. ISSN 0212-7199.
Objective: A rise in plasma levels of the amino acid homocysteine (HCY) is a possible risk factor in cardiovascular disease. The mechanisms proposed to explain how HCY can increase the risk of vascular disease include its direct effect on the vascular endothelium and its role in increasing the risk of thrombosis. The present work has been designed to determine HCY levels in patients with coronary artery disease (CAD) residents in the Canary Islands and to establish whether hyperhomocysteinemia can be considered as an risk factor. Methods: The sample studied consisted of 132 patients with, angiographically demonstrated, CAD and 18 controls with normal coronary arteries. Biochemical parameters determined included: HCY, vitamin B12, vitamin B6, folic acid, creatinine, cholesterol and its fractions, triglycerides, glucose and fibrinogen. Results: Mean levels of HCY were not significantly different between the cases and controls (p= 0.37). In the distribution of HCY levels into quintiles there was no significant association between the quintiles and the occurrence of CAD (p= 0.57). Multiple logistic regression analysis in which the risk factors were compared with quintiles 2,3,4 and 5 of HCY did not reveal a significant relation between HCY levels and risk of CAD. Conclusions: This study questions the previously accepted consideration that hyperhomocysteinemia is a risk factor of CAD. Controlled intervention trials are, therefore, necessary to clarify the possible association between total HCY levels and cardiovascular disease.
Keywords : Coronary Disease; Cardiovascular diseases; Catheterization.